Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Choosing wisely: Setting up clinical trials and research networks in India

Dr Bhawna Sirohi - Max Institute of Cancer Care, Saket, New Delhi, India and Prof Usha Menon - University College London, London, UK
Choosing wisely: Setting up clinical trials and research networks in India ( Dr Bhawna Sirohi - Max Institute of Cancer Care, Saket, New Delhi, India and Prof Usha Menon - University College London, London, UK )
20 Feb 2020

The concept of 'choosing wisely' with cancer care in India

Dr Bhawna Sirohi - Max Institute of Cancer Care, Saket, New Delhi, India
The concept of 'choosing wisely' with cancer care in India ( Dr Bhawna Sirohi - Max Institute of Cancer Care, Saket, New Delhi, India )
20 Feb 2020

Community based cancer prevention and the contribution of the environment to cancer

Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India
Community based cancer prevention and the contribution of the environment to cancer ( Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India )
20 Feb 2020

The work of Can Support in India

Dr Rivinder Mohan - Head - Knowledge, Training, Education and Research, Can Support
The work of Can Support in India ( Dr Rivinder Mohan - Head - Knowledge, Training, Education and Research, Can Support )
20 Feb 2020

Choosing wisely with breast cancer in India

Dr Shona Nag - Sahyadri Hospitals, Pune, India
Choosing wisely with breast cancer in India ( Dr Shona Nag - Sahyadri Hospitals, Pune, India )
20 Feb 2020

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Feb 2020

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

Dr Julie Graff - Oregon Health & Science University, Portland, USA
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )
19 Feb 2020

BCG dosing for bladder cancer: Standard frequency schedule correct

Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany
BCG dosing for bladder cancer: Standard frequency schedule correct ( Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany )
19 Feb 2020

RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma

Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma ( Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA )
19 Feb 2020

CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC

Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC ( Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA )
19 Feb 2020

The future of cancer care in India

Prof G.K. Rath - All India Institute of Medical Sciences, New Delhi, India
The future of cancer care in India ( Prof G.K. Rath - All India Institute of Medical Sciences, New Delhi, India )
18 Feb 2020

Choosing wisely: Lung adenocarcinoma

Dr Navneet Singh - Post Graduate Institute of Medical Education & Research, Chandigarh, India
Choosing wisely: Lung adenocarcinoma ( Dr Navneet Singh - Post Graduate Institute of Medical Education & Research, Chandigarh, India )
18 Feb 2020